May 7, 2020 / 12:25 PM / 20 days ago

BRIEF-Progenics Pharmaceuticals Q1 Loss Per Share $0.19

Progenics Pharmaceuticals Inc:

* PROGENICS PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATE

* Q1 SALES OF AZEDRA OF APPROXIMATELY $1.4 MILLION

* Q1 2020 RELISTOR WORLDWIDE NET SALES TOTAL $31.9 MILLION, UP 15% OVER Q1 2019

* PLANNED NDA SUBMISSION FOR PYL(TM) ON TRACK FOR EARLY Q3 2020

* HAS FURLOUGHED A PORTION OF CLINICAL, COMMERCIAL, AND MEDICAL EMPLOYEES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below